Legato Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.99M Sell
14,562
-1,938
-12% -$238K 0.16% 188
2026
Q1
$1.94M Sell
16,500
-3,655
-18% -$511K 0.18% 172
2025
Q4
$3.3M Sell
20,155
-945
-4% -$148K 0.28% 74
2025
Q3
$2.82M Buy
21,100
+5,100
+32% +$619K 0.31% 81
2025
Q2
$1.99M Hold
16,000
0.24% 118
2025
Q1
$2.04M Buy
16,000
+8,060
+102% +$1.24M 0.27% 98
2024
Q4
$1.14M Sell
7,940
-3,630
-31% -$521K 0.15% 257
2024
Q3
$1.72M Buy
11,570
+3,630
+46% +$521K 0.21% 149
2024
Q2
$1M Buy
7,940
+1,240
+19% +$194K 0.13% 260
2024
Q1
$1.23M Hold
6,700
0.15% 230
2023
Q4
$1.2M Hold
6,700
0.16% 218
2023
Q3
$1.07M Buy
6,700
+1,900
+40% +$311K 0.15% 227
2023
Q2
$679K Hold
4,800
0.09% 346
2023
Q1
$808K Sell
4,800
-3,314
-41% -$591K 0.15% 240
2022
Q4
$1.37M Buy
+8,114
New +$1.47M 0.26% 121
2021
Q3
Sell
-3,549
Closed -$708K 290
2021
Q2
$708K Buy
+3,549
New +$688K 0.1% 205

Other funds holding RGEN

Legato Capital Management's RGEN Position: Q2 2026 in Review

Legato Capital Management reduced its Repligen (RGEN) stake by 12% in Q2 2026, selling an estimated $238K and leaving 14,562 shares worth $1.99M. The position accounts for 0.16% of the portfolio, ranked #188.

Legato Capital Management first reported a position in RGEN in Q2 2021 and has held it in 16 quarters since. The position peaked at $3.3M in Q4 2025. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Legato Capital Management held 14,562 shares of Repligen worth $1.99M as of Q2 2026.
  • Legato Capital Management sold 1,938 Repligen shares in Q2 2026, an estimated $238K.
  • Repligen made up 0.16% of Legato Capital Management's portfolio in Q2 2026, its #188 holding.
  • Legato Capital Management first reported a position in Repligen in Q2 2021 and has held it in 16 quarters since.
  • Legato Capital Management's Repligen position peaked at $3.3M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Legato Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.